Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.03 – $0.44
21% from low
Exchange
OTC Link
ADRC
Borrow rate
0.28%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $76.1K | $525.7K | $1.0M | $1.3M | $801.4K | $0 |
| Gross profit | $0 | −$76.1K | −$526.0K | −$1.0M | −$1.3M | −$801.4K | $0 |
| Gross margin | — | — | — | — | — | — | — |
| R&D | $22.7M | $121.1M | $158.9M | $59.7M | $35.3M | $10.6M | $19.1K |
| Operating income | −$24.4M | −$135.1M | −$195.6M | −$125.2M | −$99.5M | −$38.9M | −$1.3M |
| EBITDA | −$24.4M | −$134.9M | −$195.5M | −$109.5M | $312.9M | $3.3M | −$1.3M |
| Net income | −$24.4M | −$139.8M | −$196.6M | −$110.2M | $311.1M | $2.5M | $4.9M |
| Net margin | — | — | — | — | — | — | — |
| EPS (diluted) | -0.23 | -1.33 | -1.83 | -1.02 | 2.87 | 0.02 | 0.04 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $108M | $-0.35 | $-0.35–$-0.35 | 1 |
| 2027 | $264M | $0.49 | $0.49–$0.49 | 1 |
Forward consensus · source: Financial Modeling Prep
LIANBIO SP/ADR
No one on the platform currently holds LIANY.
No tracked institution reports a position in LIANY as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-07-15 | $0.4300 | 2025-07-14 |
No one on the platform has traded LIANY yet.
| $16M |
| — |
| OXBOFOxford BioDynamics Plc | $0.00 | +0.00% | $6M | — |
| PHRRFPharmaTher Holdings Ltd. | $0.04 | +1.56% | $4M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.